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ABSTRACT

PHYSICAL THERAPIST VIEWS AND EXPERIENCES WITH PATIENT USE OF
MARIJUANA

Arturo Basurto

Conditions seen within physical therapy settings overlap with reasons that patients
seek marijuana. For this reason, information about these professionals’ outlooks on
patients’ marijuana use in prime. Purpose: Gain current views and experiences of
physical therapists (PTs)/physical therapist assistants (PTAs) on their patients’ use of
marijuana in the physical therapy field. Methods: PTs/PTAs were invited to complete an
anonymous survey asking relative PT/PTA views, experiences, and understanding of
patients’ marijuana use. Results: PTs/PTAs who have had experience (did not have
experience) with patients who use marijuana received information about marijuana from
news media - 61% (60%), patients - 68% (15%), and friends & family - 47% (35%).
72.17 percent reported having experience working with patients who use marijuana.
PTs/PTAs agreed that: marijuana has health benefits for people who suffer from chronic
debilitating conditions, there needs to be more research on the role of marijuana in
physical therapy, and training should be incorporated into PT curriculum. Discussion:
PTs/PTAs were likely to receive information about marijuana through news and their
patients; not peer-reviewed publications. PTs/PTAs who had experiences working with
patients who use marijuana could benefit from more in-depth conversations with patients
ii

about their marijuana usage. PTs/PTAs are aware of patients’ marijuana usage and
support acquiring more knowledge of marijuana through further research, education, and
conversations. Conclusion: Because PTs/PTAs have already begun working with patients
who use marijuana, it is vital that more research into the effects of marijuana is conducted
and peer-reviewed information be made available for practicing PTs/PTAs and students.
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INTRODUCTION

Many symptoms and conditions seen within the physical therapy community tend
to overlap with the reasons that patients seek the treatment pathway of marijuana
(Ciccone, 2016). Many patients of physical therapy experience spasticity, inflammation
and pain; important factors to keep to a minimum when treating patients in a physical
rehabilitation setting (Ciccone, 2016; Walsh et al., 2013). Previous research has found
that some patients who seek physical therapy also seek the use of marijuana for its uses of
pain management and muscle spasticity in addition to their rehabilitation regimen
(Reinarman, Nunberg, Lanthier, & Heddleston, 2011). With the mirroring of these
conditions within physical therapy clinics, it is logical to give attention to physical
therapists and physical therapist assistants for their opinions and experiences involving
marijuana use amongst their patients and work settings (Ciccone, 2016). Physical
therapists not only serve as the front line to a patient's rehabilitation, but also a powerful
database for alternative treatments and medicinal recommendations (Ciccone, 2016;
Doblin & Kleiman, 1991).
The United States has become enveloped in the legalization of marijuana with its
initial state of California being the first for medicinal purposes (Palamar, Ompad, &
Petkova, 2014). However, the government still holds the illicit drug accountable on the
schedule 1 drug list; blurring lines for the criminalization on utilizing it within
recreational and medical research (Bostwick, 2012). These blurred lines may also cause
gap for the proper conversations and discussions of healthcare practitioners and their
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patients. In-depth communication of whether a patient may use a marijuana-based
alternative medically or recreationally in conjunction with their therapy has a level that
remains shallow, for the fear of professionals or patients self-incriminating themselves or
risk breaking other legal terms (Voth, 2001).
The way physicians and physical therapists communicate these alternatives to
their patients play an important role in their treatment process. Exceptional training and
education for these therapists may give them the profundity in which allows them to feel
comfortable diving deeper into the conversations they have assessing their patients’
methods of marijuana usage (Chan, Knoepke, Cole, Mckinnon, & Matlock, 2017).
Moving forward, marijuana implementation within the physical therapy field requires
acknowledging the opinions and experiences of both the physical therapists and physical
therapist assistants who may have come into contact with patients who use marijuana in
conjunction with their process of physical therapy. These acknowledgements are essential
to commence progress for both parties in the proper education and understanding of
marijuana in the physical therapy field.
Thesis Statement

The purpose of this study is to understand how physical therapists and physical
therapy assistants view marijuana use in the physical therapy field and their patients’ use
of marijuana in conjunction with physical therapy. Understanding general perspectives
and viewpoints are important for physical therapists to ensure safety and enhance patient
education in the context of physical therapy intervention. In order to gain a more
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complete picture of the intersection between physical therapy and marijuana, we
surveyed current physical therapists and physical therapy assistants who may or may not
have come into contact with patients who use marijuana.
Endocannabinoid System: Brief Review

Marijuana contains approximately 100 cannabinoids, however there are two
substrates that are mainly focused on within the health community: THC and CBD. The
tetrahydrocannabinol (THC) cannabinoid tends to be responsible for the psychodynamic
effects when absorbing marijuana, while cannabidiol (CBD) has been promoted for its
therapeutic capabilities and health promotions (Ciccone, 2017). The cannabinoid system
has evolved with our species in ways that it plays a role in the regulation of pain,
memory, hunger, movement, immunity and inflammation (Aggarwal, Kyashna-Tocha, &
Carter, 2007). The human body contains two types of cannabinoid (CB) receptors: CB1
and CB2 that, when inhibited by respective endocannabinoids, cause analgesic effects.
Densely packed mainly in the central nervous system, in areas that are highly involved
with modulation of pain, lie the CB1 receptors. CB2 receptors are located outside of the
central nervous system, within lateral tissues that have immunity functions such as the
spleen (Ulugol, 2014). Synthetic Cannabinoids are developed in the medical field for
their potential abilities to replicate the functional benefits of marijuana without all the
psychodynamic effects such as: immobilization, euphoria, hypothermia, short-term
memory loss and decreased immunity responses (Chiou, Hu, & Ho, 2013). Suggestions
by Chiou et al. (2013) say that the administration of monoacylglycerol lipase (MAGL)
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inhibitors have an analgesic effect on neuropathic pain, as well as fatty acid amide
hydrolase (FAAH) having a significant part in regulating nociceptive pain when inhibited
by its induced CB1 receptor, which also showed a decrease in pain sensitivity (Chiou et
al., 2013). These cannabinoid receptors process agonist molecules called
“endocannabinoids,” which are then synthesized, released, transported and metabolized
throughout the system. As the endocannabinoids manipulate the receptors, levels of:
appetite, immunity, sleep, memory, stress, thermoregulation, addiction and analgesia
have been reported to be more desirable for patients. (Ware et al., 2010).
Methods of Consumption

There are multiple ways to consume marijuana; however, the most common
cannabinoids consumed are THC, nabilone, dronabinol and cannabidiol. Dronabinol is a
form of synthetic THC, used for suppressing the side effects of chemotherapy and
anorexia-cachexia syndrome which include nausea and vomiting. Nabilone is also a
synthetic form of THC that has been shown to aid in the management of pain in advanced
cancer patients (Pascual, Sánchez-Robles, García, & Goicoechea, 2018). Reported by
Ste-Marie, Fitzcharles, Gamsa, Ware, and Shir (2012), the most common method of
delivery for their studied population is smoked marijuana, holding 10% of a 457
population from a clinic that specializes in treating fibromyalgia. It has also been
approved to treat cancer pain by acting as an “adjuvant analgesic in malignant diseases.”
Cannabinoids may also be made into oils to be used in butters for edible products such as
candies, lozenges, cookies, pastries, drinks, and other edible products (Ciccone, 2016).
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Some marijuana products take the form of a creme (or cream) like substance and rubbed
onto the skin to be absorbed; however, it has been said to not be the most effective form
of application according to Aggarwal, Kyashna-Tocha, & Carter (2007).
When ingested, these substances enter systemic circulation and eventually effect
the central nervous system various ways. Because of the forward progression of medical
cannabis and all other alternatives alike, the FDA and the DEA have agreed to reclassify
the scheduled status of the cannabinoid: Dronabinol, to a schedule 3 from a schedule 2
for its satisfactory safety profile (Aggarwal, Kyashna-Tocha, & Carter, 2007).
Patients’ Experiences and Use of Marijuana

There are multiple reasons people utilize marijuana, otherwise known as
“cannabis” or “weed,” in combination with other treatments to manage certain symptoms.
Some users truly seek marijuana as recreational, however they use their illness as a
justification according to researchers (Ste-Marie et al., 2012). Bostwick (2012) suggests
that there is a hazy boundary between users of medical and recreational marijuana;
stating that while one seeks it for medicinal properties, the other seeks it for intoxication.
Former recreational users who have familiarized themselves with its psycho dynamic
effects are more likely to favor the therapeutic properties and continue the treatment
(Bostwick, 2012). According to Walsh et al. (2013), online surveys of self-selected
participants who use marijuana for medical purposes reported that they use marijuana to
treat multiple symptoms including insomnia, nausea, anxiety, arthritis and chronic spinal
and non-spinal spasms. Other direct symptoms of the condition including: inflammation,
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anxiety, ocular pressure and negative mood, have also been suggested reasons for the use
of marijuana. Marijuana is said to aid the side effects of multiple-sclerosis (MS); helping
to also regulate blood sugar, tics, seizures, impotence and high blood pressure (Walsh et
al., 2013).
Multiple sclerosis, fibromyalgia, distal pain, inflammation and many other
conditions are seen within the physical therapy clinics that are also associated with
patients who use marijuana. Marijuana has analgesic qualities for it attempts to relieve
pain with its side effects. For example, Abrams et al. (2007), studied the effects of
smoking marijuana cigarettes three times a day on individuals with HIV derived sensory
neuropathy; finding that marijuana use was associated with analgesic (acting to relieve
pain) effects as it progressed to relieve 34% more pain compared to a control group.
Though side effects such as: anxiety, sedation, confusion, disorientation and dizziness
were low in both populations, they were more prominent in the marijuana group (Abrams
et al., 2007).
To improve positive results of patients’ recovery, research has also suggested that
patients who are participating in a pain rehabilitation program have statistically improved
their pain status when using marijuana along with their regimen (Shah, Craner &
Cunningham, 2017). Within the Ware et al. (2010) study, participants with refractory
pain who were involved with conventional therapies that had failed, were administered
single doses of marijuana through a titanium pipe for 14 days. Results showed that these
participants were able to achieve sleep faster, fall asleep more easily and woke less
throughout the night. Additionally, participants who had chronic post-surgical or post-
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traumatic neuropathic pain reported reduced pain intensity with marijuana use.
Researchers concluded their interpretation of the results as smoked marijuana being a
positive aid towards pain reduction, improved mood and sleep assistance (Ware et al.,
2010). Additionally, individuals with fibromyalgia (FM) have reported decreases in
stress, sleeplessness and pain as a result of self-medication of cannabinoids (Ste-Marie et
al., 2012).
Health Care Practitioners Experience and Opinions on Patients’ Use of Marijuana

Physicians today are caught in limbo with educating and prescribing marijuana to
their patients without incriminating themselves into civil litigations for malpractice due to
laws and outsider points of view (Voth, 2001). For example, though the state of
Washington passed the medical marijuana initiative law, I-692, there was still no
protection for marijuana users against federal law (Aggarwal, Kyashna-Tocha, & Carter,
2007). Washington is estimated to have 1000-2000 licensed physicians prescribing
marijuana to medical patients for all types of their conditions; this magnitude is also
reflected in the state of Oregon (Aggarwal, Kyashna-Tocha, & Carter, 2007).
Doblin and Kleiman (1991) conducted a survey of 11700 oncologists in the U.S.
from backgrounds in clinical, academic and research. The results showed that a vast
majority of oncologists had patients that already use marijuana in their treatment and
have openly conversed about the risks and benefits. A majority of respondents also said
that marijuana was an effective treatment of emesis (vomiting) within their patients,
however the more inexperienced a patient was with marijuana use, the more side effects
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they would experience (Doblin & Kleiman, 1991). With many physicians’ advising their
patients to attempt a treatment that is illegal by law, outlines of how uneven general
acceptance with “clinical and regulatory opinions” are becoming more prominent (Doblin
& Kleiman, 1991).
Bega, Simuni, Okun, Chen, and Schmidt (2016) conducted a survey of physicians
treating individuals with Parkinson’s disease (PD). The results showed that a vast
majority of clinicians had patients who were prescribed and using marijuana; yet less
than a quarter of the physicians had any sort of proper education on the drug itself (Bega
et al., 2016). Furthermore, 93% of the physicians surveyed agreed that the education of
marijuana should have more focus within the medical school curriculum (Bega et al.,
2016). Authors conclude the findings in this article as a representation of the issues in
translation from the scientific evidence to clinical settings and the information that is
passed along (Bega et al., 2016). These types of issues are extremely significant and
should be taken into consideration when informing and prescribing patients (Bega et al.,
2016).
Similarly, the results of a survey distributed by Kondrad and Reid (2013) looked
at the physicians of Colorado’s attitude toward the state’s general view and practice of
marijuana. Results found that there is a dissatisfaction amongst these views of physicians
for the reason that marijuana specific training within the Colorado system has not been a
greater focus (Kondrad & Reid, 2013). This plays an important role when it comes to
prescribing marijuana and explaining its significant health effects (Kondrad & Reid,
2013). Considerations given within this study that could benefit the marijuana community
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as a whole are: strict guidelines in determining who qualifies for marijuana, requirements
of physicians to receive proper education and training before recommending marijuana
(Kondrad & Reid, 2013).
Carlini, Garrett, and Carter (2017) conducted a survey of health care professionals
in Washington State to examine their clinical practices in prescribing medicinal
marijuana (MM). Results show that the majority of responders were uncomfortable with
recommending MM to their patients, despite perceptions that marijuana could be to their
benefit (Carlini et al., 2017). When questioned what could be implemented to better their
comfortability they gave the responses: education programs for health care providers,
more clinical data, more research proving effectiveness, algorithms for recommending
MM, endorsed clinical guidelines, and change in marijuana federal legal status (Carlini et
al., 2017). In comparison with other surveys’ results, this article ties them together with
how therapists are limited to information given to their patients due to the lack of
education and other federal forces preventing marijuana acceptance within clinical
situations (Carlini et al., 2017).
Maccallum and Russo (2018) reassures the issue that a better understanding of
dosing and pharmacology for the physicians and other clinical administrators will further
the benefits and expectations of patients who use marijuana. Furthermore, negative and
positive effects of these remedies could then be communicated in terms which patients
understand; leaving little room for ignorance on this specific medicinal pathway
(Ciccone, 2016).
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Students’ Opinions on Marijuana

Student perceptions in the educational routes towards medical wellness help shape
the future of today’s human survival through the teachings of new medicines and
protocol pathways. Moeller and Woods (2015) conducted a study that looked at the
knowledge and attitudes towards marijuana via a Likert-scale survey of 311 pharmacy
students from The University of Kansas (Moeller & Woods, 2015). Results show that
students who have had previous experience with marijuana are more likely to report that
it should be legalized recreationally (54% of population) as well as medically (78% of
population) (Moeller & Woods, 2015). Students who previously had experience with
marijuana also had better scores of identifying probable uses for the treatment such as
glaucoma, schizophrenia, PD, HIV and others; showing that it is more likely for those
who have used marijuana before have more knowledge on the subject (Moeller & Woods,
2015). Reportedly, student comfortability with discussion of the marijuana with patients
were low (average: 2.1, 2.2 and 2.3); however, 90% of the students indicated that more
instruction of marijuana should be included within the curriculum (Moeller & Woods,
2015). Similarly, Chan, Knoepke, Cole, Mckinnon and Matlock (2017), conducted a
survey of students from the University of Colorado on their perceptions of using
marijuana in a healthcare setting. Results illustrated the perceived positive effects that
marijuana has on patients who suffer from cancer, cachexia, HIV/AIDS, pain, nausea,
glaucoma, seizures and persistent muscle spasms (Chan et al., 2017). Students believed
that with further research and reduction in regulations, marijuana may prove to be more
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beneficial than harmful; thus, leading to a decrease in disciplinary action against medical
professionals who prescribe marijuana (Chan et al., 2017).
Sources of Information

The source of an information may just be as important as the information itself, given the
reliability and general agreement on what the information explains. Looking at the
Carlini et al. (2017) study, participants who authorized MM to their patients had received
a majority of their information about MM from news media (54.7%), patients (70.7%),
other providers (76%), and medical journals (67.1%). Similarly, those health care
providers who have not authorized MM to their patients received a majority of their
information about MM from news media (53.2%), patients (56.7%), other providers
(53.7%), and medical journals (49.5%). In contrast, Bega et al. (2016) found that the
physicians that responded to their study, formulated their opinions based off of the
information they received from mostly from medical journals; they also reported their
own personal experience, the media, and other physicians helped shape their opinions
about marijuana. These results show that there are mixed information resources that
health care providers are utilizing to form their opinions and beliefs on the use of
marijuana in the medical field; resources that are peer-reviewed and resources that are
media-based. How will the resources that physical therapists and physical therapists
choose to utilize, factor into their opinions and experiences?
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Looking Into Physical Therapy

To our knowledge, there is no current research on examining the experiences and
opinions of medical marijuana as it pertains directly in their patients’ physical therapy
regimens. Knowledge of how marijuana can assist patients as a medical pathway needs to
be communicated and learned throughout the entire health system because natural
remedies are once again becoming a greater tool the more they are understood
scientifically. Synthetic medicine may be a powerful solution, however after analyzing
these articles, the progression of science and research in the field of marijuana may well
be as a close second. For that reason, physical therapists play key roles in the
rehabilitation of their patients and should be a strong medium for medical communication
of all sorts. Not just for the sake of instilling an additional learning system within the
physical therapy curriculum, but for the proper education of those who have yet
experienced the medical side of marijuana; not just the hallucinogenic side of that coin
(Ciccone, 2016).
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METHODS

Survey Design

The survey consisted of 37 questions within 5 sections: (1) Consent to Act as a
Research Participant, (2) Experience with Marijuana, (3) Working with Patients who Use
Marijuana, (4) Views on Marijuana Policies and (5) Demographics. Questions of these
sections are variabilities of: multiple choice, Likert-type scale and free response (fill in
the blank). They cover most situations within the physical therapy clinic that pertains to
reasons for patients’ use and therapists’ perspectives and experience on that use.
Questions asked were taken from other healthcare personnel perception studies and
adapted to be specific to physical therapy practice (Calini et al., 2017; Chan et al., 2017;
Konrad et al., 2013). Questions regarding demographics were taken from the APTA
website. The survey was accessed via a website link and took an average of 6 minutes to
complete. Questions included were able to be skipped at any time without penalty,
resulting in staggered participant responses per question.
Participants

135 total participants were recruited for the survey; two of the participants’
answers were discarded for not agreeing to the consent form. 113 indicated their
profession: physical therapists (108) and physical therapist assistants (5). Participants
comp1eted a survey that requested their opinions and experiences with marijuana, or lack
thereof, in the physical therapy field. Individuals were licensed Physical Therapist (PT)
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or Physical Therapist Assistant (PTA) who had access to a computer or other internet
streaming device and are able to read and write in the English language. PTs and PTAs
gave their experience with, perceptions of, and knowledge of marijuana; first-hand
experience is preferred but not needed. Participants were recruited for the study through
distributed flyers, word-of-mouth and emails. IRB approval was obtained prior to the
beginning of the study and all participants provided informed consent before survey
commencement.
Recruitment

After acquiring the IRB approval (#17-095), participant recruited then
commenced. Fliers, emails and messages were sent through various social media
platforms, local physical therapy clinics, the PT notes through the California Physical
Therapy Association and word of mouth throughout the physical therapy community.
Demographics and practice settings reflected a heavy participation from PTs and PTAs in
California and/or outpatient facilities. Demographics and practice settings reported by
participants (n = 116) resulted in a majority practicing in California (68.97%) with the
next highest group being from Texas (4.31%) displayed in Table 1. Practice settings of
participants (n = 116) reported majorities being outpatient facilities (45.69%), hospitalbased outpatient facilities (15.52%) and home health care organizations (11.21%)
indicated in Table 2.
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Table 1 Self-Reported State of Practice from PT and PTA Respondents*

State

% of Respondents (n = 116)

California
68.97% (n = 80)
Texas
4.31% (n = 5)
Arizona
3.45% (n = 4)
Pennsylvania
3.45% (n = 4)
Illinois
2.59% (n = 3)
Other
2.59% (n = 3)
Washington
1.72% (n = 2)
Oregon
1.72% (n = 2)
Other**
<0.87% (n = 1)
*Values are presented as a percentage of the population studied
**CO, MA, MO, IN, GA, ME, IA, KS, RI, FL, MN, MI, VA
Table 2 Self-Reported Practice Setting of PT and PTA Respondents
Setting

% of Responded Settings (n =116)

Outpatient facility
45.69% (n = 56)
Hospital based outpatient
15.52% (n = 18)
Home health
11.21% (n =13)
Acute care hospital
8.62% (n = 10)
Academic institution
7.76% (n = 9)
Other (please specify)**
6.03% (n = 7)
Health & Wellness facility
1.72% (n = 2)
Skilled nursing facility
0.86% (n = 1)
School system
0.86% (n = 1)
*Values are presented as a percentage of the population studied
**More than one setting, doctor's office, traveler, private practice, own business of one
practitioner - visit in client's home, both urban in orthopedics and rural in geriatrics, and
outpatient HMO
The average age was 43.62 ± 14.46 with 61 female, 53 male and 1 non-binary
participants (PT = 108, PTA = 5) indicated in Table 3.
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Table 3 Self-Reported Demographics of PT and PTA Respondents
Category
% of Responded Choices (n = selections)
Female
53.04% (n = 61)
Male
46.08% (n = 53)
Non-binary
0.87% (n = 1)
Physical Therapist (PT)
95.57% (n = 108)
Physical Therapist Assistant (PTA)
4.43% (n = 5)
Data collection

The surveys were conducted online and were anonymous from 2/22/2018 through
10/22/2019. Access to the surveys were through the survey generator website: Survey
Monkey. If they received the flyer, the participant went to the website indicated on it; if
they did not receive the flyer they would have been directed to the website through
another source. After informed consent was given, the participants answered as many
questions truthfully as they could until all of the questions have been passed through.
General question description has been stated above. Patients may have withdrawn from
the survey if they desired without penalties. Ideally, there would have been one answered
survey per participant.
Analysis

Descriptive statistics were used to summarize respondents’ total selection values
of each question. The surveys reported counts and percentages representing the
population of a general region and served as a sample for the population as a whole.
Answers from Survey Monkey were extracted to a Microsoft Excel spreadsheet and IBM
Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY:
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IBM Corp for analysis. After general demographics were tallied, data was separated into
PTs and PTAs who have had experience versus those who have not and further analyzed.
We compared the mean, standard deviations, percentage of, and total responses to
identical surveys of those who have had experience with marijuana against those who
have not. To simplify and create numerical value in the Likert-Scale type questions,
selection choices were given values as: 5-strongly agree, 4-agree, 3 neutral, 2-disagree,
and 1 strongly disagree. Current descriptive analyses were performed as exploratory
research and was without a prior hypothesis.
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RESULTS

When asked the sources for receiving their information 135 PTs/PTAs responded.
Participants who had prior experience with patients who use marijuana (n = 115)
indicated their primary sources of information on marijuana as news media (61%),
patients (68%), personal opinions (52%) and friends or family (47%). Those who have
not had experience with patients that use marijuana (n = 20) indicated their primary
source of information as news media (60%), Family/friends (35%), continuing education
(30%), personal experience and peer-reviewed articles (25% each). Results are presented
in Table 4.
Table 4 Self-Reported Sources of Knowledge about Marijuana from PTs and PTAs Who
May Have Had Prior Experience with Marijuana*
Information Source
Not Experienced (n = 20)
Experienced (n =115)
News media
60%
61%
Patients
15%
68%
Other providers
15%
19%
Peer-reviewed journal articles
25%
25%
Lectures
10%
23%
Friends/family
35%
47%
Dispensary owners/staff
20%
19%
Continuing Education
30%
21%
Personal experience (Med. or Rec.)
25%
40%
Personal opinion
10%
52%
I know very little about medical marijuana
20%
20%
Unsure
0%
1%
Other
15%
3%
*Values are presented as a percentage of the population studied
Abbreviations: PT, physical therapists; PTA, physical therapist assistants; Med., medical;
Rec., recreational
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Data was extracted and segregated to look only at responses that indicated that
they had prior experience with marijuana (n= 115). Within this group, PTs and PTAs
reported that they have had experience working with patients who use marijuana both
medicinally and recreationally (72.07%); others reported just recreationally (2.94%), or
just medicinally only (25%). When asked what type of products patients were known to
use, 36.36% of participants reported that their patients use non-psychoactive (CBD)
products, while 29.55% of the participants are completely unsure of what product their
patients use. Other marijuana products participants selected were: Hybrid (Sativa-Indica)
(11.36%), Sativa-dominant (10.23%), Indica-dominant (8.52%), and "other" (3.96%).
The majority of the reported ingestion methods of marijuana that patients were said to be
using were topical (24.75%), and edible methods (18.64%). Less frequently reported
were liquid tinctures (16.61%), smoking leaves (13.9%), vaporized concentrates (8.14%),
vaporized leaves (7.46%), and smoke concentrates (5.42%). Residual respondents were
unsure (4.75%) of their patient's consuming methods or chose "other" (0.34%).
Participants were asked to report their most common physical therapy and medical
treatment diagnoses and responded with fill in the blank. According to the results shown
in Table 5, PTs and PTAs reported that general pain (47.87%), as well as chronic pain
stemming from various causes, was the common physical therapy and medical diagnosis
for patients who use marijuana.
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Table 5 PTs and PTAs Report of Most Common Physical Therapy and Medical
Treatment Diagnosis for Patients They Work with Who Use Marijuana
Diagnosis
% of Reported Sample (n = 189)
Pain/Chronic Pain
36.51% (n = 69)
(Lower) Back Pain
23.81% (n = 45)
Unsure/Unobserved
9.52% (n = 18)
Arthritis
7.94% (n = 15)
Trauma induced pain
4.23% (n = 8)
Spasticity
3.70% (n = 7)
Other (exercise, mobility, seizures, epilepsy
2.65% (n = 5)
etc.)
Post-Operative
2.12% (n = 4)
Multiple Sclerosis
2.12% (n = 4)
Musculoskeletal (not specified)
2.12% (n = 4)
Cancer
1.59% (n = 3)
Neuropathy
1.59% (n = 3)
Fibromyalgia
1.06% (n = 2)
Cerebral Palsy
1.06% (n = 2)
Abbreviations: PT, physical therapist; PTA, physical therapy assistants

When asked to describe the timing of marijuana use in their patients relative to
therapy, participants were allowed to choose multiple options. Of the total choices
collected (n = 183) the majority responded that they were unsure (23.5%) of when their
patients were using marijuana in conjunction with their therapy. Other choices of when
patients used marijuana included: hours before appointments (14.21%), shortly before
appointments (10.93%), during appointments (with CBD topical applicants) (6.5%), after
appointments (6.65%), longer after appointments to assist with sleep (15.30%), days
when not attending therapy (12.57%) and other (6.01%) various times such as “times
during the day independent of therapy schedule,” “at times of pain dependency,” “before
and after sessions simultaneously,” or “not having a specific pattern of timing.”
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Respondents stated that if a patient obviously used marijuana prior to physical
therapy, changes to their treatment plan would reflect: no change (31.25%), more manual
therapy (4.69%), more therapeutic exercise (5.47%), more modalities (0.78%), more
neuromotor re-education (3.91%), or patient education about the risks of marijuana use
(3.13%). However, 34.38% of respondents said it would depend on the patient if there
was a change in the treatment plan, while 16.41% responded other situational choices
such as: “depending on method of ingestion used,” “shortening refraining on treatment
time all together,” “level of intoxication,” and “therapy setting type.” When asked to
describe the effects of marijuana on their patients’ participation, 40.82% of respondents
stated that participation was patient-dependent, though 28.57% reported that there are no
obvious changes in the patients' participation. Other answers given were that marijuana
significantly improves (5.1%), moderately improves (6.12%), moderately declines
(9.18%), and significantly declines (2.04%) patient participation in physical therapy.
Participants also gave other (8.16%) answers such as: “unsure,” “observed pain reduction
without affecting participation,” and “not having a true baseline as the patient has
consistently used marijuana prior.”
When asked their opinions about marijuana as it pertains to physical therapy
respondents who had prior experience with patients who use marijuana indicated that
training should be incorporated into PT/PTA school curricula, made available/specific for
PTs/PTAs, and that they would attend continuing education courses regarding marijuana
shown in Table 6 (m = 4.17, 4.27, 4.13, respectively). Similarly, those who have not had
experience with patients that use marijuana indicated that training should be made
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available/specific for PTs/PTAs and that they would attend continuing education courses
regarding marijuana (m = 4.32, 4.37). Both groups that have and have not had experience
with patients who use marijuana agree that there should be more research looking at the
role of marijuana on physical therapy patient populations (m = 4.58, 4.43).
Table 6 Self-Reported Likert-Scale Average Opinions about Marijuana from PTs and
PTAs Who May Have Had Prior Experience with Marijuana (mean ± SD)*
Topic
Not Experienced
Experienced
(n = 20)
(n = 115)
I am comfortable discussing marijuana with
patients.
Physical therapists and Physical therapist assistants
should play a role in patient education regarding the
risks and benefits of marijuana.
Training about marijuana should be incorporated
into PT and PTA school curricula.

3.79 ± 1.03

3.7 ± 1.03

3.89 ± 0.99

3.82 ± 0.93

4 ± 1.05

4.17 ± 0.8

Training (CME) about medical marijuana should be
available and specific for PT’s and PTA’s.

4.32 ± 0.82

4.27 ± 0.72

I would attend a continuing education course
regarding marijuana.

4.37 ± 0.68

4.13 ± 0.90

There is not enough scientific evidence regarding
med. marijuana to make any professional claims
about its use.

2.79 ± 0.92

3.12 ± 1.03

There should be more research looking at the role of
marijuana on physical therapy patient populations.

4.58 ± 0.51

4.43 ± 0.69

I am comfortable with my understanding of the
3 ± 1.05
2.71 ± 1.02
endocannabinoid system.
I am comfortable with my understanding of non3.11 ± 1.05
3 ± 1.12
psychoactive cannabidiol (CBD).
I am comfortable with my understanding of the use
3.44 ± 1.2
3.16 ± 1.04
of medical marijuana.
Abbreviations: PT, physical therapists; PTA, physical therapist assistants; Med., medical;
CBD, cannabidiol
*Likert-Scale values: 5-strongly agree, 4-agree, 3-neutral, 2-disagree, 1-strongly disagree
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DISCUSSION

The purpose of this study is to understand how physical therapists and physical
therapy assistants have experienced patients’ use of marijuana in conjunction with their
therapy regimen. We also looked at the opinions of physical therapists and physical
therapy assistants about marijuana as it pertains to the physical therapy medical field.
Participants of the study were assumed to give their honest opinions and experiences with
marijuana and the physical therapy field.
Sources of Information

PTs and PTAs who have had experience with marijuana reported that the majority
of their information stemmed from the news media, their patients, and their own personal
opinion; those who did not have experience with marijuana had the majority of their
sources of information being news media and friends/family. These results show that
whether there was previous experience with marijuana or not, the majority of the
information that PTs and PTAs are receiving comes from non-peer reviewed scientific
sources. These are similar to the previous findings of surveys given to other health
clinicians (Carlini et al., 2017). Our results reveal a similar trend with other studies
looking at marijuana in the medical field; that patients are more knowledgeable than
health care providers as they have been shown to be a primary resource of information
about this drug. Reasons for this may be in part of the government restrictions hindering
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significant amounts of research as marijuana is still classified as a schedule one drug;
preventing ethical testing amongst researchers in the United States (Piomelli et al., 2019).
PTs’ and PTAs’ Experiences with Patients Using Marijuana

Ciccone (2016) goes into detail about how physical therapist are a useful pipeline
for marijuana in the physical therapy field; with the goals being to reduce pain, spasticity
and inflammation, they can also serve as primary educators and reference to their patients
and physicians. Making marijuana a topic that can be utilized and learned allows physical
therapists and other professionals the medical headroom for investigation on old and new
products and administrations (Ciccone, 2016). PTs and PTAs in this study who reported
having experience with marijuana responded in majority of knowing that their patients
use marijuana for both medical and recreational purposes, however a third indicated that
their patients use CBD products, while a third also indicated that they are completely
unsure of what products their patients are using. These results indicate that these
professionals are aware of what their patients are using marijuana for, but are not sure
exactly the type of marijuana being used. As for the method of consumption by patients,
respondents indicated that their patients are mainly using topical and edible methods
instead of smoking and vaporizing products. Findings reveal that therapists have more
experience with their patients not using inhalation for ingestion, but eating, drinking, and
applications to the skin to take on the effects of marijuana. Because of this, participant
may be limiting their chances for any lung or breathing difficulties that may be cause by
inhalation of smoke or vapor, preventing further complications.
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Now that the types and methods of how patients use marijuana as viewed by their
therapists has been exposed, why do they use it? Therapists and assistants have reported
that the main reasons for patients’ use of marijuana that can be diagnosed with medical
and physical therapy treatments are general (chronic) pain and more specifically (lower)
back pain. These are similar to the responses that Reinarman et al. (2011) received from
physicians when questioned they approve medical marijuana patient identification cards.
These results also reflect the same findings from the Ware et al. (2010) and Abrams et al.
(2007) studies where researchers concluded that the use of marijuana within their
participants was a positive aspect in pain reduction. Respondents may have been told that
their patients are using marijuana to offset or ease the pain that comes hand in hand with
their conditions. Regardless of the patients’ condition, on multiple occasions pain has
made itself the top contender for marijuana use.
So how does timing of marijuana use factor into the equation? The majority PTs
and PTAs reported that they were unsure of when their patients used marijuana in regards
to their physical therapy appointment. This may be a result of PTs and PTAs lacking
depth in the conversations they have with patients about their marijuana use. Other top
reported timings of marijuana usage were hours before their therapy sessions or long after
appointments to assist them with their sleeping patterns. These findings indicate that if
patients are using marijuana in conjunction with their physical therapy sessions, they are
either using hours ahead of time or waiting hours after their session. In this case, the
immediate effects of their marijuana consumption are not factored in during the time
spent with therapists and assistants.

33
Shifting towards the effects of marijuana on their physical therapy experience, we
asked participants about their interactions with patients in the field while marijuana is
involved. PTs and PTAs responded that if a patient would attend physical therapy after
obviously using marijuana that changes within treatment plans would be specifically
patient dependent. However, secondary results indicate that there would be no changes in
the treatment plans at all, meaning that regardless of marijuana use, PTs and PTAs
adhered to their planned protocols. During therapy, participants who had experience with
marijuana reported effectiveness to their patients’ participation in therapy as either
predominantly patient dependent or not being affected at all. According to the results,
marijuana in the physical therapy clinic has situational to no effect on protocol change
and patient participation.
Views on Marijuana Use

Finally, when looking at the responses from the participants on their opinions
about the subject of marijuana in the physical therapy setting, those who have had
experience with marijuana and those who have not, both agree on many of the proposed
situational statements. The respondents believe that marijuana education should be made
that specifically available to meet the needs of PTs and PTAs. This is in line with the
other previously explain studies as physicians and students’ attitudes yearn for more
specific guidelines within their certain medical field (Bega, et al., 2016; Moeller &
Woods, 2015; Carlini et al., 2017). This shows that medical practitioners are aware that
there is limited training in this subject of their medical field and also agree that in order to
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progress in their field, proper exploration and protocol needs to be demonstrated in order
to responsibly relay information towards patients. Participants of this study also agree
that there should be more research looking at the role of marijuana on physical therapy
and that they would attend continuing education on the subject. These views are also seen
in the results of the Carlini et al. (2017) study where health care professionals felt that
clinical guidelines and educational programs for health care providers should be
implemented. Results from the current study contains participants that are willing to
obtain new information about marijuana as they surface through medically accepted
sources through continuing educational courses. PTs and PTAs are clearly aware that
there is a lack of education, they feel that there needs to be more research, and they are
motivated enough to attend further teachings about marijuana.
Interestingly enough, the experienced group felt less comfortable with their
understanding of the endocannabinoid system than the non-experienced group. These are
similar results to the pharmacy students who reported that they were uncomfortable with
their understanding of the endocannabinoid system and not comfortable with having
conversations about marijuana with their patients (Moeller & Woods, 2015). This is
important when considering the conversations that significant to have when treating a
patient, such as the understanding of a medical pathway and how it may impact a change
in recovery or experience.
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Limitations

With the Farm Bill Act of 2018, the regulation of hemp has been implemented
and removed from the definition of marijuana, progressing the research of CBD and other
derivatives (Abernethy, 2019). This event was enacted during the heart of data
recruitment and may have allowed more participants to feel comfortable when taking our
survey. Limitations of this study may have been the awareness of the survey, responses
may have been limited due to the distribution of the surveys and how far the word of
mouth aspect of data recruitment travelled from the Humboldt State University
Kinesiology and Recreational Administration Department. As shown above, many of the
participants were a representative of the state of California, a state where marijuana is
legal both recreationally and medically. Also, flyers were more heavily posted in physical
therapy clinics than other settings mentioned in the survey during recruitment, this may
be the reason for the other physical therapy setting being incredibly under represented, if
at all. Other limitations may be the honesty and truthfulness of the participants as they
were assumed to give their honest opinions and experiences with marijuana and the
physical therapy field while only completing one survey and not reentering multiple.
Skipping of questions was also allowed and responsible for not having consistent
participants in the results. A final limitation is that regulations limit the amount of in
depth experience we can acquire, in this case we are only legally allowed to conduct
survey participants rather than test subjects for higher quality research.
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Future Directions

Further research needs to examine the patient’s point of view and opinions of
marijuana use in conjunction with their physical therapy regimen. Also, with the
progressing legalization of marijuana, future research may be guided in the direction of
examining the effects of marijuana as it relates to recovery in patients who seek physical
therapy. Bostwick (2012), stated that marijuana shows promise in the treatment of diverse
medical situations and illnesses. Maccallum and Russo (2018) concur in that marijuana
will likely progress within medical fields if there is proper education and application as
there is for other remedies.
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CONCLUSIONS

The significance of this study is that physical therapists and physical therapy
assistants are generally aware that marijuana use takes place in the physical therapy field.
The responses received may have been based off of assumptions or conversations
between provider and patient, however, most professionals still seem to be left unsure of
the entirety of patients' marijuana usage. In other words, there is a communication gap
between therapists and their patients for reasons yet unknown. PTs and PTAs that
participated in this study have shown tendencies mirroring the results of past studies that
looked at other areas of healthcare providers. Information to these professionals is being
provided heavily through the media, patients, family, and friends. The information that
they are receiving may or may not be accurate or valid from a scientific standpoint as
they are not being directly derived from peer reviewed scientific studies. The majority of
the therapists were aware of the fact that their patients use marijuana along with their
therapy regimen but were hazy as to the methods and timing of their patients’ usage.
Therapists have reported that their patients are not smoking or vaporizing marijuana
nearly as much as they are eating, drinking and topically applying the drug to receive
benefits. The use of marijuana in the physical therapy clinic has been reported to
generally have no effect on therapists’ regimen plans nor does it generally have an effect
on patient’s participation in these protocols. These affects, if any, are also reported to be
patient and situational based. This study illuminates the incredible support of PTs and
PTAs for further education, research and training about marijuana in the physical therapy
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field. Patients should be receiving trustworthy information and treatment from
professionals who attain a significant amount of research, training, and confidence.
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APPENDIX

Section A: Consent to Act as a Research Participant

Physical Therapist Attitudes and Patient Use of Marijuana as an Adjunct to
Physical Therapy
Survey from Humboldt State University and Humboldt Institute for Interdisciplinary
Marijuana Research
Dear Colleague,
Your answers to these questions are completely anonymous.
To help maintain your privacy remember to not put any personally identifying
information (such as your name or address) on this survey.
You qualify for this study if you are a licensed physical therapist (PT) or physical
therapist assistant (PTA) and can help us a great deal by answering these questions. With
this information we can better understand Physical Therapists attitudes toward marijuana
and help others. Please only take the survey once.
Thank you for participating!
PURPOSE: The primary aim of this study is to understand how physical therapists view
patients’ use of marijuana. In order to gain a more complete picture of the intersection
between physical therapy and marijuana, we aim to survey current adult physical therapy
patients who are also prescribed marijuana. The patient perspective and use behaviors
are important for physical therapists to understand to ensure safety and enhance patient
education in the context of physical therapy intervention.
I understand that my participation in any study is entirely voluntary, that I must be at
least 18 years or older to participate, and that I may decline to enter each study or
withdraw from any of the studies at any time without jeopardy. I also understand that the
investigator may terminate my participation in the study at any time.
I consent to the following procedures:
- Filling out the attached survey on Cannabis
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Total Length of Study: 20 minutes
Location of Study: Online
Primary Investigator: Dr. Whitney Ogle DPT
I understand that the researchers will keep my participation confidential and
completely anonymous by not collecting any individually identifiable information. I
understand that by participating in research, I will receive the benefit of contributing to a
greater understanding of professionals’ attitudes and understanding of Marijuana. This
will help in the development of meaningful continuing education of marijuana and
endocannabinoids for physical therapists.
If you have any concerns with this study or questions about your rights as a participant,
contact the Institutional Review Board for the Protection of Human Subjects at
irb@humboldt.edu or (707) 826-5165.
If I have questions, I may also contact Dr. Whitney Ogle at wlo8@humboldt.edu
I have read, received a copy of, and understand this form: Yes ______; No_______
(Note: on Survey Monkey, if the respondent answers “No” they will not be able to
continue with the survey and will be sent to the last page saying “Thank you for your
time”)
Section B: Experience with Marijuana
Section C: Working with Patients who Use Marijuana
Section D: Views on Marijuana Policies
Section E: Demographics
Section B: Experience with Marijuana

From which sources have you obtained most of your information about marijuana?
(Check all that apply)







News media
Patients
Other providers
Peer-reviewed journal articles
Lectures
Friends/family
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 Dispensary owners/staff
 Continuing Education
 Personal experience (medical or recreational)
 Personal opinion
 I know very little about medical marijuana
 Unsure
 Other:
Have you ever worked with patients who use marijuana?
 No
o If no, skip to Section B
 Yes
o If yes, continue to next question
Section C: Working With Patients Who Use Marijuana

How would you describe patient use of marijuana?
• Medical marijuana use
• Recreational use
• Both
How often have you worked with patients who use marijuana?
 Frequently
 Fairly regularly
 Rarely
What is the most common medical diagnosis for the patients you work with who use
marijuana?
(Fill in the blank)
What is the most common PT treatment diagnosis for the patients you work with who use
marijuana?
(Fill in the blank)
How would you describe the timing of marijuana use in your patients relative to therapy?






Patients use hours before appointment
Patients use shortly before appointment
Patients use topical forms of marijuana/CBD during appointment
Patients use after appointment
Patients use long after appointment to assist in sleep
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 Patients use on days when they do not attend therapy
 Unknown
 Other (fill in the blank)
How are your patients consuming marijuana? (Check all that apply)
 Smoke leaf
 Vaporize leaf
 Smoke concentrates
 Vaporize concentrates
 Eat
 Apply oils/gels to skin
 Liquid tinctures
 Unsure
 Other:
What type of marijuana products are your patients using? (Check all that apply)
 Non-psychoactive CBD
 Sativa-dominant
 Indica-dominant
 Hybrid (Sativa-Indica)
 Unsure
 Other:
How would you describe the effects of marijuana on your patient participation during
therapeutic interventions?
 Significant improvements in participation
 Moderate improvements in participation
 No obvious changes in participation
 Moderate declines in participation
 Significant declines in participation
 It depends on the patient
If a patient obviously uses marijuana prior to PT, does this change your treatment plan for
the day? (Check all that apply)










No
Yes – more likely to do manual therapy
Yes – more likely to do therapeutic exercise
Yes – more likely to do modalities
Yes – more likely to do neuromotor re-education
Yes – more likely to do patient education about the risks of marijuana use
It depends on the patient
Other:
Skip
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************************************************************************
*************
Section D: Views on Marijuana Policies

(5 point Likert Scale from Strongly Agree to Strongly Disagree)
I am comfortable discussing marijuana with patients.
I am comfortable with my understanding of the endocannabinoid system.
I am comfortable with my understanding of non-psychoactive cannabidiol (CBD).
I am comfortable with my understanding of the use of medical marijuana.
Physical therapists and Physical therapist assistants should play a role in patient
education regarding risks and benefits of marijuana.
Training about marijuana should be incorporated into PT and PTA school curricula.
Training (CME) about marijuana should be available and specific for PT’s and PTA’s.
I would attend a continuing education course regarding marijuana.
Marijuana helps patients who suffer from chronic, debilitating medical conditions.
There are significant physical health benefits to using marijuana.
There are significant mental health benefits to using marijuana.
Using marijuana poses serious physical health risks.
Using marijuana poses serious mental health risks.
There is not enough scientific evidence regarding marijuana to make any professional
claims about its use.
There should be more research looking at the role of marijuana on physical therapy
patient populations.
The benefits of marijuana outweigh the risks.
Section E: Demographics
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What is your age?
What is your gender or gender identity?
 Female
 Male
 Non-binary
Are you licensed PT or PTA?
 Physical Therapist (PT)
 Physical Therapist Assistant (PTA)
How many years have you been licensed as a PT or PTA? (Fill in the blank)
In which US state do you practice? (Fill in the blank)
What is the legal status of marijuana in your state?
• Medicinal and Recreational
• Medicinal only
• Unsure
• Other (please specify):
How would you describe the location of your practice?
 Rural
 Urban
 Suburban
Where do you practice?
 Academic institution
 Acute care hospital
 Health & Wellness facility
 Hospital based outpatient
 Industry
 Inpatient
 Home health
 Outpatient facility
 Research center
 School system
 Skilled nursing facility
 Other (please specify):
 Prefer not to answer
How would you describe your clinical focus?
 Acute care
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Aquatic
Cardiovascular
Geriatric
Hand rehabilitation
Lymphedema management
Neurology
Oncology
Orthopedics
Pediatrics
Research
Sports
Women’s Health
Wound Management
Other (please specify):
Prefer not to answer

